Discontinued — last reported Q1 '18
Allowance for Doubtful Accounts Receivable (Current)
Abbott Allowance for Doubtful Accounts Receivable (Current) decreased by 0.7% to $290.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.4%, from $247.00M to $290.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows relatively stable performance with a 0.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Peer comparison
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_currentHistorical Data
| Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $519.00M | $288.00M | $274.00M | $262.00M | $272.00M | $266.00M | $259.00M | $241.00M | $247.00M | $255.00M | $261.00M | $247.00M | $259.00M | $280.00M | $292.00M | $290.00M |
| QoQ Change | — | -44.5% | -4.9% | -4.4% | +3.8% | -2.2% | -2.6% | -6.9% | +2.5% | +3.2% | +2.4% | -5.4% | +4.9% | +8.1% | +4.3% | -0.7% |
| YoY Change | — | — | — | -49.5% | — | -7.6% | -5.5% | -8.0% | -9.2% | -4.1% | +0.8% | +2.5% | +4.9% | +9.8% | +11.9% | +17.4% |
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is Abbott's allowance for doubtful accounts receivable (current)?
- Abbott (ABT) reported allowance for doubtful accounts receivable (current) of $290.00M in Q4 2025.
- How has Abbott's allowance for doubtful accounts receivable (current) changed year-over-year?
- Abbott's allowance for doubtful accounts receivable (current) increased by 17.4% year-over-year, from $247.00M to $290.00M.
- What is the long-term trend for Abbott's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Abbott's allowance for doubtful accounts receivable (current) has grown at a 0.1% compound annual growth rate (CAGR), from $288.00M to $290.00M.
- What does allowance for doubtful accounts receivable (current) mean?
- The estimated portion of customer invoices that the company expects will never be paid.